Health-related quality of life (HRQoL) measurement in cystic fibrosis (CF) allows the inclusion of the patient’s perspective in research and clinical practice. HRQoL scales have been used for many purposes and this review focuses on how HRQoL measurement has been implemented in CF research and care. Specifically, the review considers 1) the instruments used to measure HRQoL, 2) the factors that influence how people report HRQoL, 3) the monitoring of HRQoL in clinical practice, 4) HRQoL as an outcome measure in interventions and clinical trials and 5) whether HRQoL can predict survival. The challenge for the future is to use the available information to develop and evaluate psychological interventions that would be expected to improve HRQoL in children and adults with CF.
1 Suri R Metcalf C Wallis C Bush A . Assessing the usefulness of outcomes measured in a cystic fibrosis treatment trial. Respir Med2007; 101: 254–260.
2.
2 Goldbeck L Schmitz TG . Comparison of three generic questionnaires measuring quality of life in adolescents and adults with cystic fibrosis: the 36-item short form health survey, the quality of life profile for chronic diseases, and the questions on life satisfaction. Qual Life Res2001; 10: 23–36.
3.
3 Abbott J Webb AK Dodd M . Quality of life in cystic fibrosis. J R Soc Med1997; 90: 37–42.
4.
4 Quittner AL . Measurement of quality of life in cystic fibrosis. Curr Opin Pulm Med1998; 4: 326–231.
5.
5 Abbott J Gee L . Contemporary psychosocial issues in cystic fibrosis: treatment adherence and quality of life. Disabil Rehabil1998; 20: 262–271.
6.
6 Abbott J Gee L . Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design. Pediatr Drugs2003; 5: 41–56.
7.
7 Ramsey BW Astley SJ Aitken ML Burke W Colin AA Dorkin HL . Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis1993; 148: 145–151.
8.
8 Fuchs HJ Borowitz DS Christiansen DH Morris EM Nash ML Ramsey BW . Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary-function in patients with cystic-fibrosis. N Engl J Med1994; 331: 637–642.
9.
9 Quittner AL Buu A . Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr Pulmonol2002; 33: 269–276.
10.
10 Bergner M Bobbitt R Carter W Gilson BS . The Sickness Impact Profile: development and final version of a health status measure. Med Care1981; 19: 787–805.
11.
11 Hunt S McEwen J McKenna S . Measuring health status. London: Croom Helm; 1986.
12.
12 Ware J Sherbourne C . The Mos 36-item short-form health survey: conceptual framework and item selection. Med Care1992; 30: 473–481.
13.
13 Landgraf J . The child health questionnaire (CHQ): a users manual. Boston, MA: The Health Institute, New England Medical Centre; 1996.
14.
14 Varni JW Burwinkle TM Seid M . The PedsQL™ as a pediatric patient-reported outcome: reliability and validity of the PedsQL™ measurement model in 25,000 children. Expert Rev Pharmacoeconomics Outcomes Res2005; 5: 705–719.
15.
15 Kaplan R Anderson J Wu A Mathews WC Kozin F Orenstein D . The quality of well-being scale. Med Care1989; 27: S27–S43.
16.
16 The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy1990; 16: 199–208.
17.
17 O’Boyle C Browne J Hickey A . Schedule for the evaluation if individual quality of life (SEIQoL): a direct weighting procedure for quality of life domains (SEIQoL-DW): administration manual.Dublin: Royal College of Surgeons in Ireland, Department of Psychology; 1995. p. 1–9.
18.
18 Guyatt G Berman L Townsend M Pugsley SO Chambers LW . A measure of quality of life for clinical trials in chronic lung disease. Thorax1987; 42: 773–778.
19.
19 Jones PW . Quirk, FH, Baveystock, CM, Littlejohns, P. A self-complete measure for chronic airflow limitation. The St. Georges Respiratory Questionnaire. Am Rev Respir Dis1992; 145: 1321–1327.
20.
20 Henry B Aussage P Grosskopf C Goehrs J-M . Development of the cystic fibrosis questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res2003; 12: 63–76.
21.
21 Quittner A Buu A Messer M Modi A Watrous M . Development and validation of the cystic fibrosis questionnaire in the united states: a health-related quality-of-life measure for cystic fibrosis. Chest2005; 128: 2347–2354.
22.
22 Modi AC Quittner AL . Validation of a disease specific measure of health related quality of life for children with cystic fibrosis. J Pediatr Psychol2003; 28: 535–546.
23.
23 Gee L Abbott J Conway S Etherington C Webb AK . Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax2000; 55: 946–954.
24.
24 Goldbeck L Schmitz TG Henrich G Herschbach P . Questions on life satisfaction for adolescents and adults with cystic fibrosis: development of a disease-specific questionnaire. Chest2003; 123: 42–48.
25.
25 Baars RM Atherton CI Koopman HM Bullinger M Power M . The DISABKIDS group. The European DISABKIDS project: development of seven condition-specific module to measure health related quality of life in children and adolescents. Health Qual Life Outcomes2005; 3: 70. http://www.hqlo.com/content/3/1/70.
26.
26 Gee L Abbott J Conway S Etherington C Webb AK . Validation of the SF-36 for the assessment of health related quality of life in adults with cystic fibrosis. J Cyst Fibros2002; 1: 137–145.
27.
27 Bradley J Dempster M Wallace E Elborn S . The adaptation of a quality of life questionnaire for routine use in clinical practice: the CRQ in cystic fibrosis. Qual Life Res1999; 8: 65–71.
28.
28 Padilla A Olveira G Olveira C Dorado A Plata AJ Gaspar I . Validity and reliability of the St George’s Respiratory Questionnaire in adults with cystic fibrosis. Arch Bronchoneumol2007; 43: 205–211.
29.
29 Sawicki GS Sellers DE Robinson WM . Self-reported physical and psychological symptom burden in adults with cystic fibrosis. J Pain Symptom Manage2008; 35: 372–380.
30.
30 Patterson JM Wall M Berge J Milla C . Gender differences in treatment adherence among youth with cystic fibrosis: development of a new questionnaire. J Cyst Fibros2008; 7: 154–164.
31.
31 Federal Drugs Agency. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labelling claims. Health Qual Life Outcomes 2006; 4: 79. http://www.hqlo.com/content/4/1/79.
32.
32 Goss CH Quittner AL . Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc2007; 4: 378–386.
33.
33 Congleton J Hodson ME Duncan-Skingle F . Quality of life in adults with cystic fibrosis. Thorax1996; 51: 936–940.
34.
34 De Jong W Kaptein AA van der Schans CP Mannes GPM van Aalderen WMC Grevink RG . Quality of life in patients with cystic fibrosis. Pediatr Pulmonol1997; 23: 95–100.
35.
35 Abbott J Gee L . Quality of life in children and adolescents with cystic fibrosis: implications for optimising treatments and clinical trial design. Paediatr Drugs2003; 5: 41–56.
36.
36 Szyndler JE Towns SJ van Asperen PP McKay KO . Psychological and family functioning and quality of life in adolescents with cystic fibrosis. J Cyst Fibros2005; 4: 135–144.
37.
37 Wahl AK Rustoen T Hanestad BR Gjengedal E Moum T . Living with cystic fibrosis: Impact on global quality of life. Heart Lung2005; 34: 324–331.
38.
38 Britto MT Kotagal UR Hornung RW Atherton HD Tsevat J Wilmott RW . Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest2002; 121: 64–72.
39.
39 Sawyer MG Reynolds KE Couper JJ French DJ Kennedy D Martin J . Health-related quality of life of children and adolescents with chronic illness – a two year prospective study. Qual Life Res2004; 13: 1309–1319.
40.
40 Schwartz CE Sprangers MAG . Methodological approaches for assessing response shift in longitudinal quality of life research. Soc Sci Med1999; 48: 1531–1548.
41.
41 Gee L Abbott J Hart A Conway SP Etherington C Webb AK . Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros2005; 4: 59–66.
42.
42 Schmitz TG Henrich G Goldbeck L . Quality of life with cystic fibrosis – aspects of age and gender. Klin Padiatr2006; 218: 7–12.
43.
43 Arrington-Sanders R Yi MS Tsevat J Wilmott RW Mrus JM Britto MT . Gender differences in health-related quality of life of adolescents with cystic fibrosis. Health Qual Life Outcomes2006; 4: 5http://www.hqlo.com/content/4/1/5.
44.
44 Gee L Abbott J Conway SP Etherington C Webb AK . Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity. J Cyst Fibros2003; 2: 206–213.
45.
45 Abbott J Morton AM Musson H Conway SP Etherington C Gee L . Nutritional status, perceived body image and eating behaviours in adults with cystic fibrosis. Clin Nutr2007; 26: 91–99.
46.
46 Thomas C Mitchell P O’Rourke P Wainwright C . Quality of life in children and adolescents with cystic fibrosis managed in both regional outreach and cystic fibrosis center settings in Queensland. J Pediatr2006; 148: 508–516.
47.
47 Hogg M Braithwaite M Baily M Kotsimbos T Wilson JW . Work disability in adults with cystic fibrosis and its relationship to quality of life. J Cyst Fibros2007; 6: 223–227.
48.
48 Burker EJ Sedway J Carone S . Psychological and educational factors: better predictors of work status than FEV1 in adults with cystic fibrosis. Pediatr Pulmonol2004; 38: 413–418.
49.
49 Havermans T Vrijsen B Dupont L . Living and working with cystic fibrosis. J Cyst Fibros2006; 5: S86.
50.
50 Goldbeck L Zerrer S Schmitz TG . Monitoring quality of life in outpatients with cystic fibrosis: feasibility and longitudinal results. J Cyst Fibros2007; 6: 171–178.
51.
51 Abbott J Baumann U Conway S Etherington C Gee L Von Der Schulenburg JM . Cross-cultural differences in health-related quality of life in adolescents with cystic fibrosis. Disabil Rehabil2001; 22: 837–844.
52.
52 Collins JA . International differences in psychosocial well-being: comparative study of adults with epilepsy in three countries. Seizure1994; 3: 183–190.
53.
53 Baker GA Gagnon D McNulty P . The relationship between seizure frequency, seizure type and quality of life: findings from three European countries. Epilepsy Res1998; 30: 231–240.
54.
54 Erbil P Razavi D . Farvacques, Bilge, N, Van Houtte, PP. Cancer patients psychological adjustment and perception of illness: cultural differences between Belgium and Turkey. Support Care Cancer1996; 4: 455–461.
55.
55 de Haes JCJM Olschewski M . Quality of life assessment in a cross-cultural context: use of the rotterdam symptom checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer. Ann Oncol1998; 9: 745–750.
56.
56 Staab D Wenninger K Gerbert N Rupprath K Bisson S Trettin M . Quality of life in patients with cystic fibrosis and their parents; what is important besides disease severity. Thorax1998; 53: 727–731.
57.
57 Bradley J McAlister O Elborn S . Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis. Eur Respir J2001; 17: 712–715.
58.
58 Friedman EM Stewart M . An assessment of sinus quality of life and pulmonary function in children with cystic fibrosis. Am J Rhinol2006; 20: 568–572.
59.
59 Madge S Agent P . Quality of life in women with cystic fibrosis and urinary incontinence. J Cyst Fibros2008; 7: S100.
60.
60 Epker, J, Maddrey, AM, Rosenblatt, R. Pain and pain-related impairment in adults with cystic fibrosis. J Clin Psychol Med Settings1999; 6: 393–403.
61.
61 Hubbard PA Broome ME Antia LA . Pain, coping and disability in adolescents and young adults with cystic fibrosis: a Web-based study. Pediatr Nurs2005; 31: 82–86.
62.
62 Koh JL Harrison D Palermo TM Turner H McGraw T . Assessment of acute and chronic pain symptoms in children with cystic fibrosis. Pediatr Pulmonol2005; 40: 330–335.
63.
63 Ravilly S Robinson W Suresh S Wohl ME Berde CB . Chronic pain in cystic fibrosis. Pediatrics1996; 98: 741–747.
64.
64 Palermo TM Harrison D Koh JL . Effect of disease-related pain on the health-related quality of life of children and adolescents with cystic fibrosis. Clin J Pain2006; 22: 532–537.
65.
65 Festini F Ballarin S Codamo T Doro R Loganes C . Prevalence of pain in adults with cystic fibrosis. J Cyst Fibros2004; 3: 51–57.
66.
66 Chastain D . Chronic pain in CF: associated beliefs and behaviours. Pediatr Pulmonol2000; 20: 116–117.
67.
67 Bilton D Landy A Gunn E Saunders M . Is pain and discomfort common in CF adults. J Cyst Fibros2001; 1: 320.
68.
68 Abbott J . Coping with cystic fibrosis. J R Soc Med2003; 96: 42–50.
69.
69 Abbott J Dodd M Gee L Webb AK . Ways of coping with cystic fibrosis: implications for treatment adherence. Disabil Rehabil2001; 23: 315–324.
71 Moise JR Drotar D Doershuk CF Stern RC . Correlates of psychosocial adjustment among young adults with cystic fibrosis. Devel Behav Pediatr1987; 8: 141–148.
72.
72 Pinkerton P Trauer T Duncan F Hodson ME Batten JC . Cystic fibrosis in adult life: a study of coping patterns. Lancet1985; 2: 761–763.
73.
73 Pendleton SM Cavalli KS Pargament KI Nasr SZ . Religious/spiritual coping in childhood cystic fibrosis: a qualitative study. Pediatrics2002; 109: 1–11.
74.
74 Abbott J Hart A Morton A Gee L Conway S . Health-related quality of life in adults with cystic fibrosis: the role of coping. J Psychosom Res2008; 64: 149–157.
75.
75 Golbeck L Schmitz TG Buck C . Quality of life in adolescents and adults with cystic fibrosis. Monatsschr Kinderheilkd1999; 147: 823–829.
76.
76 Rustoen T Wahl AK Hanestad BR Gjengedal E Moum T . Expressions of hope in cystic fibrosis patients: a comparison with the general populations. Heart Lung2004; 33: 111–118.
77.
77 Wahl AK Rustoen T Hanestad BR Gjengedal E Moum T . Self-efficacy, pulmonary function, perceived health and global quality of life of cystic fibrosis patients. Soc Indic Res2005; 72: 239–261.
78.
78 Riekert KA Bartlett SJ Boyle MP . Krishnan, JA, Rand, CS. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest2007; 132: 231–237.
79.
79 Havermans T Colpaert K Dupont LJ . Quality of life in patients with cystic fibrosis: association with anxiety and depression. J Cyst Fibros (in press).
80.
80 Sawyer MG Reynolds KE Couper JJ French DJ Kennedy D Martin J . A two-year prospective study of the health-related quality of life of children with chronic illness – the parents’ perspective. Qual Life Res2005; 14: 395–405.
81.
81 Congleton J Hodson ME Duncan-Skingle F . Do Nottingham Health Profile scores change over time in cystic fibrosis. Respir Med1998; 92: 268–272.
82.
82 Schwartz CE Rapkin BD . Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal. Health Qual Life Outcomes2004; 2: 16http://www.hqlo.com/contents/2/1/16.
83.
83 Ring L Hofer S Heuston F Harris D O’Boyle CA . Response shift masks the treatment impact on patient reported outcomes (PROs): the example of individual quality of life in edentulous patients. Health Qual Life Outcomes2005; 3: 55http://www.hqlo.com/contents/3/1/55.
84.
84 Glasscoe C Quittner A . Psychological interventions for cystic fibrosis. Cochrane Database of Systematic Reviews2008; (3): CD003148.
85.
85 Spahr JE Love RB Francois M Radford K Meyer KC . Lung transplantation for cystic fibrosis: current concepts and one center’s experience. J Cyst Fibros2007; 6: 334–350.
86.
86 Quattrucci S Rolla M Cimino G Bertasi S Cingolani S Scalercio F . Lung transplant for cystic fibrosis: 6-year follow-up. J Cyst Fibros2005; 4: 107–114.
87.
87 Burker EJ Carels RA Thompson LF Rodgers L Egan T . Quality of life in patients awating lung transplant: cystic fibrosis versus other end-stage lung diseases. Pediatr Pulmonol2000; 30: 453–460.
88.
88 Feltrim MIZ Rozanski A Borges ACS Cardoso CA Caramori ML Pego-Fernandes P . The quality of life of patients on the lung transplantation waiting list. Transplant Proc2008; 40: 819–821.
89.
89 Taylor JL Smith PJ Babyak MA Barbour KA Hoffman BM Sebring DL . Coping and quality of life in patients awaiting lung transplantation. J Psychosom Res2008; 64: 71–79.
90.
90 Hadjiliadis D . Special considerations for patients with cystic fibrosis undergoing lung transplantation. Chest2007; 131: 1224–1231.
91.
91 Kugler C Fischer S Gottlieb J Welte T Simon A Haverich A . Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant2005; 24: 2262–2268.
92.
92 Vermeulen KM van der Bij W Erasmus ME Dulverman EJ Koeter GH TenVergert EM . Improved quality of life after lung transplantation in individuals with cystic fibrosis. Pediatr Pulmonol2004; 37: 419–426.
93.
93 Smeritschnig B Jaksch P Kocher A Seebacher G Aigner C Mazhar S . Quality of life after lung transplantation: a cross-sectional study. Heart Lung Transplant2005; 24: 474–480.
94.
94 Ullrich G Jaensch H Niedermeyer J . Quality of life in young adults after lung transplantation: only a matter of improved performance. Transplant Med2004; 16: 202–202.
95.
95 Griffiths AL Jamsen K Carlin JB Grimwood K Carzino R Robinson PJ . Effects of segragation on a epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med2005; 171: 1020–1025.
96.
96 Goven JR Brown PH Maddison J Doherty CJ Nelson JW Dodd M . Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet1993; 342: 15–19.
97.
97 Al-Aloul M Crawley J Winstanley C Hart CA Ledson MJ Wakshaw MJ . Increased morbidity with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax2004; 59: 334–336.
98.
98 Jones AM . webb AK, Goven, JR, Hart, CA, Walshaw, MJ. Pseudomonas aeruginosa cross-infection in cystic fibrosis. Lancet2002; 359: 527–528.
99.
99 Duff AJA . Psychological consequences of segregation resulting from chronic Burkholderia cepacia infection in adults with cystic fibrosis. Thorax2002; 57: 756–758.
100.
100 Waine DJ Whitehouse J Honeybourne D . Cross-infection in cystic fibrosis: the knowledge and behaviour of adult patients. J Cyst Fibros2007; 6: 262–266.
101.
101 Koscik RL Douglas JA Zaremba K Rock MJ Splaingard ML Laxova A . Quality of life in children with cystic fibrosis. J Pediatr2005; 147: S64–S68.
102.
102 Schmitz TG Goldbeck L . The effect of inpatient rehabilitation programmes on quality of life in patients with cystic fibrosis: a multi-center study. Health Qual Life Outcomes2006; 4: 8http://www.hqlo.com/content/4/1/8.
103.
103 Wolter JM Bowler SD Nolan PJ McCormack JG . Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. Euro Respir J1997; 10: 896–900.
104.
104 Esmond G Butler M McCormack AM . Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis. J Clin Nurs2006; 15: 52–60.
105.
105 Yi MS Tsevat J Wilmott RW Kotagal UR Britto MT . The impact of treatment of pulmonary exacerbations on the health-related quality of life of patients with cystic fibrosis: does hospitalization make a difference. J Pediatr2004; 144: 711–718.
106.
106 Abbott J Hart A . Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review. Health Qual Life Outcomes2005; 3: 19http://www.hqlo.com/contents/3/1/19.
107.
107 Elkins M Robinson M Rose BR . A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med2006; 354: 241–250.
108.
108 Donaldson SH Bennett W Zeman KL Knowles MR Tarran R Boucher RC . Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med2006; 354: 229–240.
109.
109 Hardin DS Adams-Huet B Brown D Chatfield B Dyson M Ferkol T . Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicentre randomized controlled trial. J Clin Endocrinol Metab2006; 91: 4925–4929.
110.
110 Clement A Tamalet A Leroux E Ravilly S Fauroux B Jais J-P . Long term effects of azithromycin in patients with cystic fibrosis: a double blind placebo controlled trial. Thorax2006; 61: 895–902.
111.
111 Grover P Thomas W Moran A . Glargine versus NPH insulin in cystic fibrosis related diabetes. J Cyst Fibros2008; 7: 134–136.
112.
112 Watson H Bilton D Truby H . A randomized controlled trial of a new behavioural home-based nutritional education programme, ‘Eat well with CF’, in adults with cystic fibrosis. J Am Diet Assoc2008; 108: 847–852.
113.
113 Wilson CJ Robbins LJ Murphy JM Chang AB . Is a longer time interval between recombinant human deoxyribonuclease (Dornase alpha) and chest physiotherapy better. Pediatr Pulmonol2007; 42: 1110–1116.
114.
114 Abbott J Morton A Hart A Conway SP Webb AK . Can patient-reported health-related quality of life predict survival in cystic fibrosis. J Cyst Fibros2007; 6: S77.
115.
115 Bredemeier J Gomes WB . Perception of quality of life of persons with cystic fibrosis: a study on the adequacy of rating scales. Rev Psiquiatr Rio Gd Sul2007; 29: 35–43.
